Incannex Healthcare Inc
IXHL0.445USD
+0.059+15.36%
收盤 08/04, 16:00（美東）報價延遲15分鐘
7.91M總市值
虧損本益比TTM
關於 Incannex Healthcare Inc 公司
Incannex Healthcare Inc. 是一家臨牀階段的藥物開發公司。該公司正在開發醫用大麻素藥物產品和迷幻藥療法，用於治療阻塞性睡眠呼吸暫停 (OSA)、創傷性腦損傷 (TBI) 和腦震盪、肺部炎症（ARDS、COPD、哮喘、支氣管炎）、類風溼性關節炎、炎症性腸病、焦慮症、成癮症和疼痛等。該公司的多元化產品組合包括 28 個不同的研發 (R&D) 項目和 6 個正在進行的臨牀試驗。其臨牀項目包括IHL-42X阻塞性睡眠呼吸暫停、IHL-675A炎症性肺病、IHL-675A類風溼性關節炎、IHL-675A炎症性腸病、IHL-216A腦震盪和TBI、用於治療焦慮的PSI-GAD裸蓋菇素、MedChew GB帶狀皰疹後神經痛和MedChew-1401多發性硬化症中的疼痛和痙攣。
公司簡介
公司代碼IXHL
公司名稱Incannex Healthcare Inc
上市日期Mar 18, 2022
CEOMr. Joel Latham
員工數量9
證券類型Ordinary Share
年結日Mar 18
公司地址8 Century Circuit
城市
上市交易所NASDAQ Capital Market Consolidated
國家Australia
郵編2153
電話61409840786
網址
公司代碼IXHL
上市日期Mar 18, 2022
CEOMr. Joel Latham
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Joel Latham
Mr. Joel Latham
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
1.24M
-21.24%
Dr. George Anastassov
Dr. George Anastassov
Non-Executive Independent Director
Non-Executive Independent Director
744.72K
-3.25%
Mr. Lekhram Changoer
Mr. Lekhram Changoer
Chief Technology Officer
Chief Technology Officer
639.55K
--
Mr. Peter Widdows
Mr. Peter Widdows
Non-Executive Independent Director
Non-Executive Independent Director
245.85K
-9.23%
Mr. Joseph Swan
Mr. Joseph Swan
Chief Financial Officer, Controller, Treasurer, Company Secretary
Chief Financial Officer, Controller, Treasurer, Company Secretary
17.93K
-89.40%
Mr. Troy Valentine
Mr. Troy Valentine
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Dr. Luigi M. (Lou) Barbato, M.D.
Dr. Luigi M. (Lou) Barbato, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Robert B. Clark
Mr. Robert B. Clark
Non-Executive Independent Director
Non-Executive Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Joel Latham
Mr. Joel Latham
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
1.24M
-21.24%
Dr. George Anastassov
Dr. George Anastassov
Non-Executive Independent Director
Non-Executive Independent Director
744.72K
-3.25%
Mr. Lekhram Changoer
Mr. Lekhram Changoer
Chief Technology Officer
Chief Technology Officer
639.55K
--
Mr. Peter Widdows
Mr. Peter Widdows
Non-Executive Independent Director
Non-Executive Independent Director
245.85K
-9.23%
Mr. Joseph Swan
Mr. Joseph Swan
Chief Financial Officer, Controller, Treasurer, Company Secretary
Chief Financial Officer, Controller, Treasurer, Company Secretary
17.93K
-89.40%
Mr. Troy Valentine
Mr. Troy Valentine
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
收入明細
FY2025Q1
FY2024
FY2024Q4
FY2022
暫無數據
地區USD
名稱
營收
佔比
Australia
74.00K
0.00%
業務
地區
暫無數據
股東統計
更新時間: 7月16日 週三
更新時間: 7月16日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Great Point Capital LLC
6.55%
L1 Capital Global Opportunities Master Fund Ltd.
6.55%
S.H.N. Financial Investments Ltd
6.55%
Latham (Joel)
4.22%
Valentine (Troy Robert)
2.95%
Other
73.17%
持股股東
持股股東
佔比
Great Point Capital LLC
6.55%
L1 Capital Global Opportunities Master Fund Ltd.
6.55%
S.H.N. Financial Investments Ltd
6.55%
Latham (Joel)
4.22%
Valentine (Troy Robert)
2.95%
Other
73.17%
股東類型
持股股東
佔比
Corporation
13.11%
Individual Investor
13.03%
Investment Advisor
8.09%
Hedge Fund
0.35%
Research Firm
0.18%
Investment Advisor/Hedge Fund
0.03%
Other
65.22%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
39
10.24M
34.78%
+3.35M
2025Q1
36
6.86M
34.69%
+1.54M
2024Q4
34
5.22M
29.25%
-10.87K
2024Q3
35
5.23M
32.43%
+928.92K
2024Q2
32
5.32M
33.29%
+935.04K
2024Q1
33
4.38M
27.39%
+2.50M
2023Q4
26
4.32M
27.01%
+2.81M
2023Q3
13
32.37K
0.05%
-34.33K
2023Q2
11
12.21K
0.02%
-63.09K
2023Q1
10
20.53K
0.03%
-60.83K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Great Point Capital LLC
1.93M
6.55%
+1.93M
--
Apr 09, 2025
L1 Capital Global Opportunities Master Fund Ltd.
1.93M
6.55%
+460.27K
+31.34%
Apr 09, 2025
S.H.N. Financial Investments Ltd
1.93M
6.55%
+1.93M
--
Apr 09, 2025
Latham (Joel)
1.24M
4.22%
-335.00K
-21.24%
Apr 09, 2025
Valentine (Troy Robert)
869.01K
2.95%
-167.50K
-16.16%
Apr 09, 2025
Anastassov (George)
744.72K
2.53%
-25.00K
-3.25%
Apr 09, 2025
Changoer (Lekhram)
639.55K
2.17%
--
--
Apr 09, 2025
AdvisorShares Investments, LLC
295.03K
1%
+129.54K
+78.27%
Mar 31, 2025
Widdows (Peter)
245.85K
0.84%
-25.00K
-9.23%
Apr 09, 2025
Citadel Advisors LLC
102.87K
0.35%
+102.87K
--
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
AdvisorShares Psychedelics ETF
0.73%
Amplify Alternative Harvest ETF
0%
AdvisorShares Psychedelics ETF
佔比0.73%
Amplify Alternative Harvest ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
